Evolv Technologies, Inc. Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Evolv Technologies Holdings, Inc. (EVLV) – Deadline is December 31, 2024… Read MoreJoin Investigation
Checkpoint Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) securities between March 10, 2021 and December 15, 2023 (the “Class Period”). Click Here to Join Investigation. … Read MoreJoin Investigation
The Chemours Company Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”)(NYSE: CC). Click Here To Join Investigation…. Read MoreJoin Investigation
Doximity, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of the common stock of Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) between February 9, 2022 and April 1, 2024 (the “Class Period”)…. Read MoreJoin Investigation
Vestis Corporation Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS)…. Read MoreJoin Investigation
